LABD vs. COTG
LABD (Direxion Daily S&P Biotech Bear 3x Shares) and COTG (Leverage Shares 2X Long COST Daily ETF) are both Leveraged Equities funds. LABD is passively managed, while COTG is actively managed. At a 0.12 correlation, their price movements are largely independent. LABD charges 1.06%/yr vs 0.75%/yr for COTG.
Performance
LABD vs. COTG - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, LABD achieves a -35.70% return, which is significantly lower than COTG's 20.04% return.
LABD
- 1D
- -8.36%
- 1M
- -3.30%
- YTD
- -35.70%
- 6M
- -34.69%
- 1Y
- -81.85%
- 3Y*
- -51.16%
- 5Y*
- -42.46%
- 10Y*
- -56.12%
COTG
- 1D
- 2.32%
- 1M
- -9.84%
- YTD
- 20.04%
- 6M
- 10.13%
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
LABD vs. COTG - Yearly Performance Comparison
| 2026 (YTD) | 2025 | |
|---|---|---|
LABD Direxion Daily S&P Biotech Bear 3x Shares | -35.70% | -52.99% |
COTG Leverage Shares 2X Long COST Daily ETF | 20.04% | -21.71% |
Correlation
The correlation between LABD and COTG is 0.12, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (All Time) Calculated using the full available price history since Sep 19, 2025 | 0.12 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
LABD vs. COTG — Risk / Return Rank
LABD
COTG
LABD vs. COTG - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Direxion Daily S&P Biotech Bear 3x Shares (LABD) and Leverage Shares 2X Long COST Daily ETF (COTG). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| LABD | COTG | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | — | — | |
| Sortino ratioReturn per unit of downside risk | — | — | |
| Omega ratioGain probability vs. loss probability | 0.74 | — | — |
| Calmar ratioReturn relative to maximum drawdown | -0.99 | — | — |
| Martin ratioReturn relative to average drawdown | -1.33 | — | — |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| LABD | COTG | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -1.08 | — | — |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.44 | — | — |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | -0.59 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.55 | -0.21 | -0.34 |
Drawdowns
LABD vs. COTG - Drawdown Comparison
The maximum LABD drawdown since its inception was -99.99%, which is greater than COTG's maximum drawdown of -25.69%. Use the drawdown chart below to compare losses from any high point for LABD and COTG.
Loading charts...
Drawdown Indicators
| LABD | COTG | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.99% | -25.69% | -74.30% |
Max Drawdown (1Y)Largest decline over 1 year | -83.21% | — | — |
Max Drawdown (3Y)Largest decline over 3 years | -95.31% | — | — |
Max Drawdown (5Y)Largest decline over 5 years | -98.24% | — | — |
Max Drawdown (10Y)Largest decline over 10 years | -99.98% | — | — |
Current DrawdownCurrent decline from peak | -99.99% | -21.71% | -78.28% |
Average DrawdownAverage peak-to-trough decline | -90.93% | -8.42% | -82.51% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 61.58% | — | — |
Volatility
LABD vs. COTG - Volatility Comparison
Loading charts...
Volatility by Period
| LABD | COTG | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 28.88% | — | — |
Volatility (6M)Calculated over the trailing 6-month period | 62.11% | — | — |
Volatility (1Y)Calculated over the trailing 1-year period | 76.10% | 40.63% | +35.47% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 96.33% | 40.63% | +55.70% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 95.95% | 40.63% | +55.32% |
LABD vs. COTG - Expense Ratio Comparison
LABD has a 1.06% expense ratio, which is higher than COTG's 0.75% expense ratio.
Dividends
LABD vs. COTG - Dividend Comparison
LABD's dividend yield for the trailing twelve months is around 7.04%, while COTG has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
COTG Leverage Shares 2X Long COST Daily ETF | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
LABD Direxion Daily S&P Biotech Bear 3x Shares | 7.04% | 6.67% | 4.68% | 6.13% | 0.53% | 0.00% | 3.94% | 1.75% | 0.81% |
Frequently Asked Questions
LABD and COTG have a correlation of 0.12, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, COTG is cheaper at 0.75% per year. The better choice depends on whether you care most about return, fees, risk, or income.
COTG is cheaper with a 0.75% expense ratio, compared with 1.06% for LABD.
LABD has the higher dividend yield at 7.04%, compared with 0.00% for COTG.
They also come from different issuers: Direxion and Leverage Shares. Their fees differ too: 1.06% for LABD and 0.75% for COTG.
Find the right allocation for LABD and COTG
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer